Blood and Plasma-Derived Product Approvals in India: Regulatory and Quality Expectations
Posted by: Mahima Sahrawat July 31, 2026
Blood and Plasma-derived Medicinal products (PDMP Read More
Blood Products
Notification for revision in Ceiling prices of Anti-tetanus Immunoglobulin 250 IU & 500 IU’ under Para 19 based on the decision of 147th Authority meeting held on 11.06.2026
Posted by: Prabhas Chakraborty June 19, 2026
Read MoreRevised Regulatory Guidelines For Sampling Of Drugs, Cosmetics & Medical Devices By Drugs Inspectors Of Central & State Drug Authorities
Posted by: Hitesh Gupta May 29, 2026
Read MoreDisposal/Rejection of Long Pending Applications on SUGAM Portal Awaiting Query Response
Posted by: Hitesh Gupta May 6, 2026
Read MoreGuidance document on dossier based licensing of Drugs for uniform product licensing in the country
Posted by: Hitesh Gupta April 1, 2026
Read More2026.03.09 G.S.R. 164(E)_Draft Notification regarding Blood product testing under Drugs Rules,1945
Posted by: Hitesh Gupta March 27, 2026
Read MoreImplementation of Prior intimation System for Forms CT-10, CT-12 and CT-13 in pursuance of G.S.R. 46(E) dated 20.01.2026
Posted by: Hitesh Gupta March 11, 2026
Read More